A Randomised, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension (NCT05975905)
KER-012-A201
This trial is No longer recruiting
Registration number NCT05975905
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Helen Whitford
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR